PLANO, Texas, Feb. 05, 2016 -- Denbury Resources Inc. (NYS:DNR) ("Denbury" or the "Company") will host a conference call to review and discuss fourth quarter and full-year 2015 financial and operating results and year-end 2015 proved reserves on Thursday, February 18, 2016 at 10:00 A.M. (Central). The Company plans to issue its financial and operating results prior to the market opening on the same day. Individuals who would like to participate should dial the applicable dial-in number listed below ten minutes before the scheduled start time.
| What: Denbury Resources Fourth Quarter and Full-Year 2015 Results Conference Call |
| Date: Thursday, February 18, 2016 |
| Time: 10:00 A.M. (Central) / 11:00 A.M. (Eastern) |
| Dial-in numbers: 800.230.1096 (domestic) and 612.332.0725 (international) |
| Conference ID number: 324020 |
A live presentation webcast of the conference call will be available on the Company's website at www.denbury.com. The webcast will be archived on the website and a telephonic replay will be accessible for at least one month after the call by dialing 800.475.6701 (domestic) or 320.365.3844 (international) and entering the conference ID number: 324020.
Denbury is an independent oil and natural gas company with operations focused in two key operating areas: the Gulf Coast and Rocky Mountain regions. The Company's goal is to increase the value of its properties through a combination of exploitation, drilling and proven engineering extraction practices, with the most significant emphasis relating to carbon dioxide enhanced oil recovery (CO2 EOR) operations. For more information about Denbury, please visit www.denbury.com.
DENBURY CONTACTS: Ross Campbell, Manager of Investor Relations, 972.673.2825 Ben Nelson, Financial Analyst, 972.673.2787


Italy Fines Apple €98.6 Million Over App Store Dominance
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study 



